Coave Therapeutics (“Coave”), a company redefining targeted gene therapy with a best-in-class pipeline powered by ...

IITM Pravartak's Advanced Certificate Programme in Agentic AI and RAG Engineering aims to equip professionals with skills to build production-ready AI systems.

Groundbreaking AAV-based gene therapy offers potential treatment for patients with OTOF gene-associated severe-to-profound and profound hearing lossWhite Oak, Md., April 24, 2026 (GLOBE NEWSWIRE) -- ...

The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...

Defender’s advantage for territory denial: drones alter the ratio of force required to overcome an entrenched defender.

Researchers have long considered the Stuxnet attacks on Iran's nuclear centrifuges in Natanz to be the opening chapter of ...

Aedes aegypti, commonly known as the yellow fever mosquito, is a highly adapted, invasive mosquito species recognized as a major global health threat that acts as the primary vector for several severe ...

Biotechnology stocks have seen a spike in merger and acquisition (M&A) activity. In March 2026 alone, there were 10 deals valued at approximately $31.5 billion. A key reason for this activity is ...

As cell and gene therapy leaders gathered in Maryland to discuss accelerating clinical trials in children, one “cutting edge” ...

Zilliz, the creator of Milvus -- the world's most widely adopted open-source vector database with over 43,000 GitHub stars and more than 10,000 enterprise deployments -- has been recognized as a ...

(NASDAQ: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, recently announced findings from a real-world study ...

Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical ...